Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0000899243-22-034751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 | 2022-10-31 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.25 | +99.8K | 5.38M | +2% | +$224.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | P | A | 99,801 | $2.25 | 5,377,839 | D | — | — |